{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:20:04Z","timestamp":1765995604271,"version":"build-2065373602"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative early recurrence (ER) poses a major threat to long-term survival in hepatocellular carcinoma (HCC), especially in patients with microvascular invasion (MVI). Although conventional staging systems provide prognostic guidance, they are often inadequate for capturing recurrence risk in this high-risk subgroup. To develop and validate a CART-based prognostic model tailored to ER risk stratification and assessment of long-term outcomes following curative hepatectomy in MVI-positive HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort of 440 patients with histologically confirmed HCC and MVI who underwent curative resection was analyzed. ER-associated predictors were identified via multivariable Cox regression and used to construct a classification and regression tree (CART) algorithm. Model discrimination, calibration, and clinical utility were evaluated using time-dependent ROC curves and decision curve analysis. Predictive performance for recurrence-free survival (RFS) and overall survival (OS) was compared against established staging systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eight independent factors predictive of ER were identified: HBV-DNA load, tumor size, Edmondson-Steiner grade, tumor capsule integrity, MVI classification, satellite nodules, Ki-67 index, and CK19 expression. The CART model demonstrated robust discriminative ability (C-statistic: 0.773 in training; 0.764 in validation), and consistently outperformed conventional staging systems. Furthermore, CART-defined risk strata were significantly associated with both RFS and OS (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This CART-based framework provides a transparent and clinically implementable tool for ER risk stratification in MVI-positive HCC. By outperforming existing staging algorithms, it offers a basis for individualized surveillance and postoperative management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1655739","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:14:26Z","timestamp":1761279266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A CART-based prognostic model for risk stratification of postoperative early recurrence in hepatocellular carcinoma with microvascular invasion"],"prefix":"10.3389","volume":"15","author":[{"given":"Jie","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri-Jin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Xiang","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Zhou","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Yun","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001269","article-title":"Critical Update: AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"82","author":"Taddei","year":"2025","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0807581","article-title":"Recurrence of hepatocellular carcinoma","volume":"359","author":"Sherman","year":"2008","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003268","article-title":"Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation","volume":"273","author":"Lee","year":"2021","journal-title":"Ann Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i42.9279","article-title":"Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update","volume":"22","author":"Cong","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"HepatologyHepatology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31821ad884","article-title":"Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria","volume":"254","author":"Lim","year":"2011","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07227-9","article-title":"Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma","volume":"26","author":"Erstad","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","article-title":"Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma","volume":"70","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12885-021-07969-4","article-title":"Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion","volume":"21","author":"Mai","year":"2021","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13821","article-title":"Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000488035","article-title":"Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition)","volume":"7","author":"Zhou","year":"2018","journal-title":"Liver Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome H\u00e9patocellulaire","volume":"31","author":"Chevret","year":"1999","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20486","article-title":"Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score","volume":"40","author":"Kudo","year":"2004","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27219","article-title":"Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients","volume":"34","author":"Ueno","year":"2001","journal-title":"Cancer Liver Ital Program Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2018-099450","article-title":"Self-efficacy and risk of persistent shoulder pain: results of a Classification and Regression Tree (CART) analysis","volume":"53","author":"Chester","year":"2019","journal-title":"Br J Sports Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.23.00220","article-title":"Classification and regression trees to predict for survival for patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab","volume":"8","author":"Brown","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S441623","article-title":"C-reactive protein-albumin ratio (CAR): A more promising inflammation-based prognostic marker for patients undergoing curative hepatectomy for hepatocellular carcinoma","volume":"17","author":"Mai","year":"2024","journal-title":"J Inflammation Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/s12885-024-12535-9","article-title":"A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension","volume":"24","author":"Ye","year":"2024","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104118","article-title":"A classification and regression tree analysis identifies subgroups of childhood type 1 diabetes","volume":"82","author":"Achenbach","year":"2022","journal-title":"EBioMedicine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3376-9","article-title":"The significance of classifying microvascular invasion in patients with hepatocellular carcinoma","volume":"21","author":"Sumie","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/jca.29490","article-title":"KIAA0101 is a novel transcriptional target of FoxM1 and is involved in the regulation of hepatocellular carcinoma microvascular invasion by regulating epithelial-mesenchymal transition","volume":"10","author":"Zhang","year":"2019","journal-title":"J\u00a0Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.4769","article-title":"FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition","volume":"8","author":"Xu","year":"2012","journal-title":"Int J Biol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","article-title":"Vasculogenic mimicry in carcinogenesis and clinical applications","volume":"13","author":"Luo","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/or.16.4.693","article-title":"Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma","volume":"16","author":"Sun","year":"2006","journal-title":"Oncol Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-20-480","article-title":"2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights","volume":"9","author":"Xie","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-010-1211-1","article-title":"High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection","volume":"14","author":"Qu","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.4257","article-title":"Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the milan criteria","volume":"151","author":"Lei","year":"2016","journal-title":"JAMA Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02126-9","article-title":"Incomplete tumor capsule on preoperative imaging reveals microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"44","author":"Zhu","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijc.2910310104","article-title":"Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation","volume":"31","author":"Gerdes","year":"1983","journal-title":"Int J Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2019.01.011","article-title":"Ki-67 protein as a tumour proliferation marker","volume":"491","author":"Menon","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12885-023-10503-3","article-title":"Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28768","article-title":"Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods","volume":"234","author":"Mehrpouya","year":"2019","journal-title":"J Cell Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304351","article-title":"Keratin 19: a key role player in the invasion of human hepatocellular carcinomas","volume":"63","author":"Govaere","year":"2014","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-021-05107-w","article-title":"CK19 predicts recurrence and prognosis of HBV positive HCC","volume":"26","author":"Shuyao","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314032","article-title":"Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy","volume":"67","author":"Zhou","year":"2018","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: A meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12885-020-06806-4","article-title":"Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation","volume":"20","author":"Mishra","year":"2020","journal-title":"BMC Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19712","article-title":"Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers","volume":"13","author":"Luo","year":"2025","journal-title":"PeerJ"},{"key":"B48","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.3350\/cmh.2022.0247","article-title":"Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease","volume":"29","author":"Seif El Dahan","year":"2023","journal-title":"Clin Mol Hepatol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1655739\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:14:26Z","timestamp":1761279266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1655739\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":48,"alternative-id":["10.3389\/fonc.2025.1655739"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1655739","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"1655739"}}